Zeria Pharmaceutical Co., Ltd. (TYO:4559)
2,070.00
-51.00 (-2.40%)
Aug 25, 2026, 3:24 PM JST
Zeria Pharmaceutical Market Cap
Zeria Pharmaceutical has a market cap or net worth of 93.49 billion as of August 24, 2026. Its market cap has increased by 2.36% in one year.
Market Cap
93.49B
Enterprise Value
102.49B
Revenue
91.12B
Ranking
n/a
PE Ratio
11.36
Stock Price
2,070.00
ChartMarket Cap Chart
Since December 22, 1998, Zeria Pharmaceutical's market cap has increased from 58.12B to 93.49B, an increase of 60.87%. That is a compound annual growth rate of 1.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 93.49B | 1.05% |
| Dec 30, 2025 | 92.52B | -14.05% |
| Dec 30, 2024 | 107.64B | 21.07% |
| Dec 29, 2023 | 88.91B | -11.00% |
| Dec 30, 2022 | 99.90B | 12.78% |
| Dec 30, 2021 | 88.58B | 0.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nippon Shinyaku | 247.16B |
| Towa Pharmaceutical | 191.74B |
| Sawai Group Holdings | 188.47B |
| Kissei Pharmaceutical | 169.75B |
| Kaken Pharmaceutical | 150.90B |
| Mochida Pharmaceutical | 115.25B |
| KYORIN Pharmaceutical | 66.52B |
| ASKA Pharmaceutical Holdings | 61.62B |